Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
5.64
-0.01 (-0.18%)
At close: Jan 15, 2026, 4:00 PM EST
5.58
-0.06 (-1.06%)
After-hours: Jan 15, 2026, 7:59 PM EST
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $38.06 million as of January 15, 2026. Its market cap has decreased by -46.74% in one year.
Market Cap
38.06M
Enterprise Value
-25.46M
1-Year Change
-46.74%
Ranking
Category
Stock Price
$5.64
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $38.06M, a decrease of -96.45%. That is a compound annual growth rate of -44.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 38.13M | -0.37% |
| Dec 31, 2025 | 38.27M | -45.94% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |